BACKGROUND: In stroke due to middle cerebral artery (MCA) occlusion, collaterals may sustain tissue in the peripheral MCA territory, extending the time window for recanalizing therapies. However, MCA occlusions often block some or all of the 'lenticulostriate' (LS) arteries originating from the M1 segment, eliminating blood flow to dependent territories in the striatum, which have no collateral supply. This study examines whether mechanical thrombectomy (MTE) can avert imminent striatal infarction in patients with acute MCA occlusion. METHODS: 279 patients with isolated MCA occlusion subjected to MTE were included. Actual LS occlusions and infarctions were assigned to predefined 'LS occlusion' and 'LS infarct' patterns derived from known LS vascular anatomy. The predictive performance of LS occlusion patterns regarding ensuing infarction in striatal subterritories was assessed by standard statistical measures. RESULTS: LS occlusion patterns predicted infarction in associated striatal subterritories with a positive predictive value (PPV) of 91% and a negative predictive value of 81%. In 15 of the 22 patients who did not develop the predicted striatal infarctions, reassessment of angiographies revealed LS vascular supply variants that explained these 'false positive' LS occlusion patterns, raising the PPV to 96%. Symptom onset to recanalization times were relatively short, but this alone could not account for the false positive LS occlusion patterns in the remaining seven of these patients. CONCLUSIONS: With currently achievable symptom onset to recanalization times, striatal infarctions are determined by MCA occlusion sites and individual vascular anatomy, and cannot normally be averted by MTE, but there are exceptions. Further study of such exceptional cases may yield important insights into the determinants of infarct growth in the hyperacute phase of infarct evolution. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: In stroke due to middle cerebral artery (MCA) occlusion, collaterals may sustain tissue in the peripheral MCA territory, extending the time window for recanalizing therapies. However, MCA occlusions often block some or all of the 'lenticulostriate' (LS) arteries originating from the M1 segment, eliminating blood flow to dependent territories in the striatum, which have no collateral supply. This study examines whether mechanical thrombectomy (MTE) can avert imminent striatal infarction in patients with acute MCA occlusion. METHODS: 279 patients with isolated MCA occlusion subjected to MTE were included. Actual LS occlusions and infarctions were assigned to predefined 'LS occlusion' and 'LSinfarct' patterns derived from known LS vascular anatomy. The predictive performance of LS occlusion patterns regarding ensuing infarction in striatal subterritories was assessed by standard statistical measures. RESULTS:LS occlusion patterns predicted infarction in associated striatal subterritories with a positive predictive value (PPV) of 91% and a negative predictive value of 81%. In 15 of the 22 patients who did not develop the predicted striatal infarctions, reassessment of angiographies revealed LS vascular supply variants that explained these 'false positive' LS occlusion patterns, raising the PPV to 96%. Symptom onset to recanalization times were relatively short, but this alone could not account for the false positive LS occlusion patterns in the remaining seven of these patients. CONCLUSIONS: With currently achievable symptom onset to recanalization times, striatal infarctions are determined by MCA occlusion sites and individual vascular anatomy, and cannot normally be averted by MTE, but there are exceptions. Further study of such exceptional cases may yield important insights into the determinants of infarct growth in the hyperacute phase of infarct evolution. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Philipp Bücke; Marta Aguilar Pérez; Elisabeth Schmid; Christian H Nolte; Hansjörg Bäzner; Hans Henkes Journal: Clin Neuroradiol Date: 2017-01-31 Impact factor: 3.649
Authors: Christian Maegerlein; Maria Teresa Berndt; Sebastian Mönch; Kornelia Kreiser; Tobias Boeckh-Behrens; Manuel Lehm; Silke Wunderlich; Claus Zimmer; Benjamin Friedrich Journal: Clin Neuroradiol Date: 2018-11-09 Impact factor: 3.649
Authors: D Byrne; G Sugrue; E Stanley; J P Walsh; S Murphy; E C Kavanagh; P J MacMahon Journal: AJNR Am J Neuroradiol Date: 2017-08-10 Impact factor: 3.825
Authors: Christian Maegerlein; Benjamin Friedrich; Maria Berndt; Kristin Elizabeth Lucia; Lucas Schirmer; Holger Poppert; Claus Zimmer; Jaroslav Pelisek; Tobias Boeckh-Behrens; Johannes Kaesmacher Journal: Interv Neuroradiol Date: 2017-10-23 Impact factor: 1.610
Authors: A P Wessell; H D P Carvalho; E Le; G Cannarsa; M J Kole; J A Stokum; T Chryssikos; T R Miller; S Chaturvedi; D Gandhi; K Yarbrough; S R Satti; G Jindal Journal: AJNR Am J Neuroradiol Date: 2020-05 Impact factor: 3.825
Authors: Johannes Kaesmacher; Christian Maegerlein; Mirjam Kaesmacher; Claus Zimmer; Holger Poppert; Benjamin Friedrich; Tobias Boeckh-Behrens; Justus F Kleine Journal: J Am Heart Assoc Date: 2017-02-15 Impact factor: 5.501
Authors: Benjamin Friedrich; Donald Lobsien; Christian Maegerlein; Silke Wunderlich; Claus Zimmer; Johannes Kaesmacher; Justus Kleine Journal: Oncotarget Date: 2016-12-27
Authors: Johannes Kaesmacher; Thomas Huber; Manuel Lehm; Claus Zimmer; Kathleen Bernkopf; Silke Wunderlich; Tobias Boeckh-Behrens; Nathan W Manning; Justus F Kleine Journal: Front Neurol Date: 2017-06-19 Impact factor: 4.003